The documents discuss new combination therapies to treat breast cancer and HIV. A Boston study found a combination of epigenetic and protease inhibitor drugs effectively inhibited growth and increased death of breast cancer cell lines. Scientists also discovered a safer method of using zinc finger nuclease proteins to disrupt specific genes as an alternative to experimental HIV gene therapy, reducing risks of viral incorporation into cellular DNA or excessive off-target DNA cuts. The new therapies offer hope for developing more effective and safer treatments for breast cancer and HIV.